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The adaptor protein Src homology 2 domain-containing leu-
kocyte phosphoprotein of 76 kDa (SLP-76) plays a crucial role in
T cell activation by linking antigen receptor (T cell receptor,
TCR) signals to downstream pathways. At its N terminus,
SLP-76 has three key tyrosines (Tyr-113, Tyr-128, and Tyr-145,
“3Y”) aswell as a sterilemotif (SAM)domainwhose function is
unclear. We showed previously that the SAM domain has two
binding regions that mediate dimer and oligomer formation. In
this study, we have identified SAMdomain-carrying non-recep-
tor tyrosine kinase, activated Cdc42-associated tyrosine kinase
1 (ACK1; also knownasTnk2, tyrosine kinasenon-receptor 2) as
a novel binding partner of SLP-76. Co-precipitation, laser-scan-
ning confocal microscopy, and in situ proximity analysis con-
firmed the binding of ACK1 to SLP-76. Further, the interaction
was induced in response to the anti-TCR ligation and abrogated
by the deletion of SLP-76 SAM domain (SAM) or mutation of
Tyr-113, Tyr-128, and Tyr-145 to phenylalanine (3Y3F). ACK1
induced phosphorylation of the SLP-76 N-terminal tyrosines
(3Y) dependent on the SAM domain. Further, ACK1 promoted
calcium flux and NFAT-AP1 promoter activity and decreased
themotility ofmurine CD4 primary T cells on ICAM-1-coated
plates, an event reversed by a small molecule inhibitor of ACK1
(AIM-100). These findings identify ACK1 as a novel SLP-76-
associated protein-tyrosine kinase that modulates early activa-
tion events in T cells.
T cell receptor (TCR)2 signaling ismediated by the activation
of protein-tyrosine kinases such as p56lck and ZAP-70 (1, 2). In
mature T cells, CD4 and CD8 molecules bind to p56lck (3–5),
which then phosphorylates the intracellular immune receptor
tyrosine-based activation motifs in the TCR-associated CD3
subunits for ZAP-70 recruitment. Binding of ZAP-70 to CD3 
is an initial step in the transduction of signaling cascades,
resulting in the phosphorylation of various molecules, includ-
ing the linker for the activation of T cells (LAT) and the SH2
domain-containing leukocyte protein of 76 kDa (SLP-76) (1, 2,
4, 6–9). The phosphorylated LAT and SLP-76 proteins func-
tion as scaffolds to recruit many other signaling molecules to
formmultimeric complexes (10, 11). SLP-76 has been shown to
be needed for thymic differentiation andmature T cell function
(12, 13). Its loss impairs the activation of phospholipase C1
(PLC1) calcium mobilization, and adhesion (14–16). Upon
TCR engagement, SLP-76 migrates to the immunological syn-
apse (17) and forms microclusters (18). Adaptor LAT in motile
vesicles can be also found with surface SLP-76 microclusters
during T cell-APC interaction (19). SLP-76 can also back-reg-
ulate ZAP-70 microcluster formation, an event that could
ensure that signaling components are in balance for optimal T
cell activation (20). In addition, SLP-76 can bind toRanGAP1of
the nuclear pore complex and directly regulate the nuclear
transport of the transcription factors NFATc1 and NF-B (21).
Structurally, SLP-76 is comprised of four domains: a sterile 
motif (SAM) domain, an acidic region with three tyrosine res-
idues (Tyr-113, Tyr-128, and Tyr-145) at the N terminus, a
central proline-rich domain, and a C-terminal Src homology 2
(SH2) domain. The N-terminal SAM domain is essential for
optimal thymic differentiation and cell activation (22, 23). SAM
domains are known to interact with themselves or with other
SAM domain-containing proteins or non-SAM domain-con-
taining proteins in a homotypic or heterotypic fashion (24).
This binding versatility allows them to regulate diverse biolog-
ical functions ranging from signal transduction to transcrip-
tional regulation (25). Despite this, the molecular events regu-
lating SAM domain-dependent functions of SLP-76 have yet to
be deciphered.
The N terminus tyrosines (3Y) are essential for supporting T
cell effector functions, including NFAT promotor activity (20,
21, 26). ZAP-70-mediated phosphorylation of the SLP-76 tyro-
sine residues 113, 128, and 145 constitutes a key TCR signaling
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event (14, 27). Cells lackingZAP-70havediminishedphosphor-
ylation of SLP-76 (28). Genetic deletion of ZAP-70 results in
severe combined immunodeficiency in both mouse and
human, with a dramatic reduction in the number of peripheral
CD4 and CD8 T cells, making it difficult to assess the role of
additional kinases in peripheral signaling (29). On the other
hand, interleukin 2 tyrosine kinase-deficient cells with defec-
tive phosphorylation of PLC1 and calcium mobilization (30)
can be complementedwith a related kinase, resting lymphocyte
kinase, which phosphorylates SLP-76, leading to the phosphor-
ylation of PLC1, activation of ERKs, and the synergistic up-
regulation of TcR-driven IL-2 NFAT/AP-1 transcription (31).
Recently, we have identified a unique role for the SAM
domain of SLP-76 in the regulation of T cell activation (22).We
observed that the SAM domain is comprised of two binding
regions that lead to the formation of dimers and higher-order
oligomers. SAM domain (1–78 residues)-deficient SLP-76
(SAM) fails to form microclusters and to enhance anti-CD3-
driven NFAT/AP-1 transcription. Mapping revealed an  helix
5 (H5) within the SAM domain that contributed to its ability to
self-associate. Retention of H5 in the absence of other helices
(H1-H4) was sufficient to support T cell activation and micro-
cluster formation, albeit at a higher rate compared with wild-
type SLP-76 (22).
Despite this progress, the mechanisms underlying SAM
domain functions remain unclear. In this study, we have exam-
ined the capacity of the SLP-76 SAM domain to interact with
other SAM domain-carrying proteins. We investigated kinases
retrieved from the Sugen/Salk Kinase Database (KinBase) pres-
ent in the human kinome (32, 33) that contained several SAM
kinases with N-terminal SAM domains. We reasoned that the
N-terminal domains may have evolved an ability to interact
with otherN-terminal domains. This led to the identification of
activated cell division cycle 42 (Cdc42)-associated tyrosine
kinase 1 (ACK1) as a kinase that associates with SLP-76 in a
SAM-dependentmanner and regulates its phosphorylation and
aspects of T cell signaling.
Results
ACK1 binds SLP-76 via SAM-SAM interaction
The N terminus SAM domain of SLP-76 is essential for opti-
mal T cell signaling, microcluster formation, IL-2 production,
andNFAT activity (22). However, little is understood regarding
molecular events regulating these functions. Previous studies
have documented the importance of ZAP-70-mediated phos-
phorylation of SLP-76 in the regulation of T cell responses (28).
It has remained an open questionwhether other kinases exist in
T cells that mediate SLP-76 phosphorylation and promote its
function. In particular, we were interested in whether SAM
domain-carrying kinases could bind to SLP-76, leading to its
phosphorylation. A search of several databases, including Kin-
Base, led to the identification of the N-terminal SAM domain
kinases ACK1 (or Tnk2, tyrosine kinase non-receptor 2) and
ACK2 (or Tnk1, tyrosine kinase non-receptor 1) (Fig. 1A).
Intriguingly, the highest expression levels of ACK1 are found in
the spleen, the thymus, and the brain (34). Analysis of entries
in the microarray database also showed the highest expres-
sion of ACK1 in lymphocytes, such as CD4 conventional and
regulatory T cell populations, which was further confirmed
by quantitative real-time-PCR andWestern blotting (supple-
mental Fig. S1).
SAM-containing proteins can bind other proteins and form
homo- or heterodimers and may even formmultimers (22, 35).
To evaluate the possible interaction of ACK1 with endogenous
SLP-76, Myc-tagged ACK1 was expressed in Jurkat T cells by
transfection, followed by ligation with 2 or 4 g/ml of soluble
anti-CD3 for 5 min. ACK1 protein was precipitated with anti-
Figure 1. SLP-76 binds to ACK1. A, representation of the ACK1 and ACK2 domain architecture. UBA, ubiquitin-associated; CRIB, Cdc42- and Rac-interactive
bindingmotif. B, anti-SLP-76 co-precipitates ACK1. Jurkat cells were transfected withMyc-tagged ACK1, left resting (lane 1), or stimulated at 24 h with soluble
anti-CD3 (2g/ml, lane 2) or (4g/ml, lane 3) for 5min, followedby immunoprecipitation (IP)with anti-Myc andblottingwith anti-Mycor SLP-76.C, anti-SLP-76
co-precipitates ACK1 fromprimarymouse T cells. Immunoprecipitation used anti-SLP-76 fromprimary T cells isolated frommouse spleen. Primary T cells were
either left resting (lane 1) or incubated for 5 min with anti-CD3 (lane 2).
Ack1 regulates SLP-76 phosphorylation
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Myc antibody (Fig. 1B). A small amount of endogenous SLP-76
was co-precipitated with anti-Myc (Fig. 1B, lane 1), which was
markedly increased with anti-CD3 (Fig. 1B, lanes 2 and 3). As
controls, anti-Myc detected Myc-ACK1 and anti-SLP-76
detected SLP-76 in cell lysates (Fig. 1B, bottom panels). These
results indicated that endogenous SLP-76 could be co-precipi-
tated with transfected ACK1, and the associationwas increased
with anti-CD3 stimulation. We also observed binding in mu-
rine primary resting mouse T cells by precipitation using an
anti-SLP-76 antibody followed by anti-ACK1 blotting (Fig. 1C).
Purified CD4 T cells were isolated from mouse spleen and
activated with soluble anti-CD3 for 5min. Anti-SLP-76 co-pre-
cipitated ACK1 in resting cells (Fig. 1C, left panel, lane 1) that
was increased with anti-CD3 (Fig. 1C, left panel, lane 2, and
right panel). Binding between SLP-76-EYFP and Myc-ACK1
could also be observed in transfected non-hematopoietic
HEK293T cells (Fig. 2,A, lane 2, and B, lane 6).Additionally, in
situ proximity hybridization (PLA) of ACK1 and SLP-76 gave a
positive signal that was indicative of close proximity in
HEK293T cells (Fig. 2C, top left panel, yellow dots). Together,
these findings indicate, for the first time, thatACK1 and SLP-76
bind to each other in different cell lines, including Jurkat and
primary T cells.
To assess the binding sites between ACK1 and SLP-76, we
expressed various SLP-76 mutants in non-hematopoietic
HEK293T cells with Myc-tagged ACK1 (Fig. 2A). Anti-SLP-76
co-precipitated the Myc-ACK1 protein and wild-type SLP-76
(Fig. 2A, lane 2). By contrast, anti-SLP-76 co-precipitated a
much reduced ACK1 band from cells expressing the mutant
SLP76-SAM (residues 1–78 deletion) (Fig. 2A, lane 6) or
Figure 2. ACK1 binding to SLP-76 is dependent on the SLP-76 SAM domain and three proximal tyrosine residues: Tyr-113, Tyr-128, and Tyr-145. A,
ACK1 binding to the SLP-76 mutant in HEK293T cells. Various SLP-76 mutants (wild-type SLP-76, proximal tyrosine mutant (3Y3F), or SAM-deficient (SAM)
SLP-76) were expressed with Myc-tagged ACK1. Cells were transfected for 24 h before harvesting. Lysates were subjected to immunoprecipitation (IP) with
anti-GFP antibody, capturing SLP-76 and bound ACK1 (lane 2). No binding was seenwithSAM (lane 6) or the 3Y3Fmutant (lane 4). The percentage of bound
ACK1 is shown in the right panel. B, unlike the 3Y3Fmutant, theHA-tagged single tyrosinemutants Y128F and Y145F failed to disrupt the SLP76-ACK1 complex
(lanes 2 and 4). C, left panel, in situ proximity ligation assay (PLA) showing co-localization of Myc-ACK1 with HA-SLP-76 (red dots, top row) but not with
SLP76-SAM (center row) or 3Y3F mutants (bottom row). No binding was seen in controls. Right panel, binding assessed by immunoprecipitation from the
lysates of samples used in the PLA. The results in C are representative of two experiments and in A and B representative of four experiments performed in two
different laboratories.
Ack1 regulates SLP-76 phosphorylation
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SLP-76 lacking proximal tyrosines 3Y3F (tyrosine-to-phenyla-
lanine mutants) (Fig. 2A, lane 4). By contrast, in another exper-
iment, a single mutation of Tyr-128 or Tyr-145 to phenylala-
nine did not disrupt binding (Fig. 2B, lanes 2 and 4), suggesting
possible cooperativity among the three tyrosine residues.
Further, in an in situ proximity ligation assay (PLA), anti-
Myc and anti-HA antibodies were employed with the
DuolinkTM detection system in HEK293T cells (Fig. 2C). Cells
were transfected with Myc-ACK1 to bind anti-Myc and HA-
tagged SLP-76 to bind anti-HA. From this, a strong signal was
seen between ACK1 and SLP-76 (Fig. 2C, left panel, top left).
This was consistent with the co-precipitation of Myc-ACK1 in
anti-HA precipitates of HA-SLP-76 (Fig. 2C, right panel, lane
4). By contrast, co-expression of Myc-ACK1 with HA-SLP76-
SAM(Fig. 2C, left panel, center row) orHA-SLP76–3Y3F (Fig.
2C, left panel, bottom row) failed to show a positive PLA signal
or to be co-precipitated in anti-HA SLP-76 precipitations (Fig.
2C, right panel, lanes 5 and 6). Collectively, these findings
showed that the interaction between ACK1 and SLP-76 was
dependent on the SLP-76 SAM domain and proximal tyrosine
residues at 113, 128, and 145.
Consistent with these findings, we next showed the co-local-
ization of SLP-76 and ACK1 using laser-scanning confocal
microscopy of Jurkat cells on anti-CD3-coated glass coverslips
(Fig. 3, left panel). Cells were imaged over a time course in
response to anti-CD3 ligation. Representative 3Dprojections of
deconvolved images of T cells treated with anti-CD3 (Fig. 3, top
right panel, a (0 min), c (2 min), e (5 min), and g (10 min)) were
used to assess the co-localization coefficient (Fig. 3, top right
panel, b, d, f, and h). An increase in co-localization was seen in
response to anti-CD3 by 2 min, and this remained stable until
10 min. Pearson’s correlation coefficient values of 0.51 at 2 min
and 0.49 at 5 min revealed significant overlap between SLP-76
(green) and ACK1 (red) upon stimulation compared with the
resting control group (Fig. 3, bottom panel, histogram). Anti-
body specificity controls are shown in supplemental Fig. S1D).
These findings provide strong evidence of SLP-76 binding to
ACK1.
ACK1 phosphorylates SLP-76-proximal tyrosine residues
In vitro and in vivo studies have demonstrated that tyrosines
113, 128, and 145 in the acidic N-terminal region of SLP-76 are
Figure 3. Laser confocal imaging shows that ACK1 co-localizes with SLP-76 in Jurkat T-cells. Left panel, laser confocal images showing co-localization of
SLP-76 (green) with ACK1 (red), with nuclear DAPI shown in blue. Cells were treatedwith anti-CD3 for 2min (top row) to 10min (bottom row). Top right panel, 3D
projections of deconvolved confocal images of SLP-76 (green) and ACK1 (red) in T cells. a, c, e, and g, confocal microscope images of Jurkat T cells treated with
anti-CD3 for 0, 2, 5, and 10min, respectively. Each image is an overlay of green (SLP-76-EYFP) and red (HA-ACK1). b, d, f, and h, 2D co-localization histograms at
0, 2, 5, and10min, respectively. Pearson’s correlation coefficient value is shown in the top right corners. Bottom right panel,meandegreeof colocalization S.D.
Datawere statistically analyzed using one-way analysis of variance. The p values for each treated group represent statistically significant differences compared
with the control group (bottom right panel, table). All treated groups showa significant difference comparedwith the control resting group (0min), whereas 10
min appears to be most significant (p 0.005) among all groups. Images are representative of three independent experiments performed in two different
laboratories. CTRL, control.
Ack1 regulates SLP-76 phosphorylation
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critical for supporting T cell functions (27, 28). These tyrosines
are phosphorylated by ZAP-70 kinase (28, 36). Given our evi-
dence that SLP-76 binds to ACK1, we next investigated
whether ACK1 can also phosphorylate SLP-76. We co-ex-
pressed SLP-76-EYFP or the 3Y3F-SLP76-EYFP mutant with
ACK1 or empty vector in HEK293T cells, followed by precipi-
tation with anti-GFP and blotting with various antibodies (Fig.
4). Expression of SLP-76 with empty vector revealed no detect-
able tyrosine phosphorylation (Fig. 4A, lane 1). By contrast,
ACK1co-expressionwithSLP-76resultedinitssignificantphos-
phorylation (Fig. 4A, lane 2). Further, ACK1 failed to phosphor-
ylate the SLP-76 tyrosine mutant 3Y3F lacking all three proxi-
mal tyrosines (Fig. 4A, lane 4).
In view of the result showing that deletion of the SAM
domain disrupted binding of ACK1 to SLP-76 (Fig. 2A), we also
assessedwhether the loss of this domain affected tyrosine phos-
phorylation. SLP-76wild-type, SLP76-SAM, or 3Y3Fwere co-
expressed with ACK1 (Fig. 4B). SLP-76 was then immunopre-
cipitated, and tyrosine phosphorylation was assessed by
blotting. As before, wild-type SLP-76 became phosphorylat-
ed when co-expressed with ACK1 (Fig. 4B, lane 2). However,
the SLP76-SAM mutant (Fig. 4B, lane 6) and the 3Y3F
mutant (Fig. 4B, lane 4) failed to become tyrosine-phosphor-
ylated. The binding data showed that ACK1 sustained bind-
ing to Y128F and Y145F mutants, suggesting that two of
three unmutated tyrosines are sufficient for binding (Fig.
2B). Based on this, we speculated that mutation of a single
tyrosine residue in the 3Y motif will still permit phosphory-
lation of the remaining intact tyrosines (i.e.Tyr-113 and Tyr-
145 when Tyr-128 is mutated and Tyr-113 and Tyr-128
when Tyr-145 is mutated). Unexpectedly, however, a point
mutation of Tyr-128 or Tyr-145 to phenylalanine abolished
phosphorylation of the entire 3Ymotif (Fig. 4C). This finding
demonstrates that ACK1 concurrently phosphorylates all
three residues and requires an intact N-terminal SAM and
the three N-terminal tyrosines. The Tyr-113 mutant was not
included in this study. Therefore, the likelihood of Tyr-128
and Tyr-145 being co-phosphorylated in the absence of Tyr-
113 could not be ruled out. However, these results suggest
concurrent phosphorylation of tyrosines 113, 128, and 145.
ACK1 increases calcium flux and NFAT transcription
Emphasizing the critical role of the 3Y residues, previous
studies have established that, in SLP-76-deficient cells, the
3Y3F mutant fails to rescue PLC1 phosphorylation, calcium
flux, and NFAT transcriptional activity (37). To determine the
functional consequence of ACK1 in this context, we made use
of CD4 primary mouse T cells transfected with ACK1 or a
control vector (Fig. 5A). Cells were loadedwith the intracellular
calcium indicator Indo-1 dye and assessed for their ability to
support the influx of extracellular calcium in response to sub-
optimal anti-CD3 concentrations. CD4 T cells expressing
ACK1 showed an enhanced influx of calcium in response to
anti-CD3. Anti-Myc blotting confirmed the expression of
transfected protein (Fig. 5A, fourth panel). Consistent with this,
ACK1 exogenous expression also increased NFAT/AP1 pro-
moter activity (Fig. 5B).
In addition, the effect of ACK1 on T cell motility was exam-
ined (Fig. 6). ACK1 has been implicated previously in hepato-
cellular carcinoma metastasis (38). We observed a decrease in
the random motility of T cells upon exogenous ACK1 expres-
sion compared with wild-type cells on ICAM-1-coated plates
(Fig. 6, left panel). Further, consistent with this, inhibition of
endogenous ACK1 activity by pretreatment of cells with an
ACK1 inhibitor (AIM-100) resulted in significantly increased
cell motility compared with untreated cells. However, the
detailed role of ACK1 in synapse formation and integrin signal-
ing will be addressed in future studies. These results strengthen
the evidence that the ACK1 gene is a positive regulator of T cell
Figure 4. ACK1 mediates phosphorylation of SLP-76 3Y proximal tyrosines. A, phosphorylation of SLP-76 by ACK1 was assessed by co-transfecting
HEK293T cells with ACK1 andWT SLP76-EYFP (lane 2) or tyrosinemutant SLP-76 (3Y3F-EYFP, lane 4) for 24 h, followed by SLP-76 immunoprecipitation (IP) with
anti-GFP, and total tyrosine phosphorylation was assessed by 4G10 (anti-Tyr(P)) antibody (first blot). SLP-76 immunoprecipitation efficiency was assessed by
anti-SLP76blotting (second blot), whereas transfection efficiencywas assessedby blotting of lysateswith anti-Myc (for ACK1) and anti-SLP-76 (forWT and 3Y3F
SLP-76). B, ACK1-mediated phosphorylation requires SLP-76 to possess an intact N terminus, as shown by loss of phosphorylation in SLP76-SAM (lane 6) and
3Y3F (lane 4) SLP-76 mutants. WT SLP-76 (lane 2) was efficiently tyrosine-phosphorylated. No detectable phosphorylation was seen in control cells co-
transfectedwithemptyMyc-taggedvector (lanes 1,3, and5).C, pointmutationof Tyr-128orTyr-145abrogated tyrosinephosphorylationofunmutatedTyr-113
and Tyr-145 (lane 2) or Tyr-113 and 128 (lane 4), respectively. Co-transfection of SLP-76 or its mutants with empty vector (lanes 1, 3, and 5) served as a negative
control. All blots shown are representative of at least three to four independent experiments. For comparison purposes, the data for Fig. 4, B and C, are derived
using the same input lysates as used in Fig. 2, A and B, respectively.
Ack1 regulates SLP-76 phosphorylation
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function and that deregulation of its function may lead to
pathologies such as cancer (39).
Discussion
The adaptor protein SLP-76 plays a pivotal role in the trans-
mission of signals from the TCR to the transcriptional machin-
ery (37). The identity of the full range of associated kinases that
bind and phosphorylate SLP-76 is not known. Previous studies
from us and others have shown that ZAP-70 phosphorylates
SLP-76 in the modulation of its function (27, 28). Here we have
identified a new non-receptor SAM domain-carrying protein-
tyrosine kinase, ACK1, that binds to SLP-76, resulting in the
phosphorylation of its key tyrosine residues at Tyr-113, Tyr-
128, and Tyr-145. Binding was abrogated by the deletion of the
SLP-76 SAMdomain (SAM) or bymutation of three key tyro-
sine (3Y3F) residues in the N terminus of SLP-76. Functionally,
ACK1 promoted calcium flux and NFAT-AP1 promoter activ-
ity and decreased the randommotility ofmurineCD4primary
T cells on ICAM-1-coated plates. An increase in motility was
observed uponACK1 inhibition by the smallmolecule inhibitor
Figure 5. ACK1 enhanced anti-CD3-induced calcium flux andNFAT activity. A, primary CD4 T-cells transfectedwith ACK1 (first and third panels) or vector
(secondpanel)were loadedwith Indo-1dye, followedby stimulationwith anti-CD3 (0. 25g/ml). Theplots show the ratio of bound to freedyeon the y axiswith
time (on the x axis, inminutes). Calcium flux in response to anti-CD3 in vector-transfected (second panel) or ACK1-transfected (third panel) primary CD4 T-cells
is shown. The first panel shows the baseline without anti-CD3 stimulation. ACK1 expression was assessed byWestern blotting (fourth panel). B, ACK1 results in
enhancedNFAT-AP1 activity in Jurkat T cells transfectedwith exogenousMyc-ACK1 (blue columns) or vector (silver columns). Transfected cells were stimulated
for 6 hwith soluble anti-CD3 (2g/mlOKT3) and 1g/ml of rabbit anti-mouse IgG crosslinking antibody. 3NFAT/AP1promoter-driven luciferase activitywas
measured with the Dual-Luciferase assay kit (Promega). The data shown are normalized to Renilla luciferase and representative of at least two independent
experiments. ns, not significant; **, p 0.01; ***, p 0.001); unpaired Student’s t test (mean S.E.).
Figure 6. ACK1 slows T cell motility. Left panel, motility (displacement) of CD4 T-cells on ICAM-1-Fc-coated plates that were pretransfected with either
emptyvector (bluedots) orACK1 (reddots)measuredby live-cell imaging. Inset, expressionofACK1byWesternblotting.Right panel, displacementofCD4 cells
that were pretreatedwith either ACK1 inhibitor (AIM-100) or control (DMSO), tracked on ICAM-1-Fc-coated plates. 15–20 individual cells (represented by dots)
for each condition were analyzed by Volocity software. *, p 0.05; **, p 0.01; unpaired Student’s t test (mean S.E.).
Ack1 regulates SLP-76 phosphorylation
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AIM-100. These findings identify ACK1 as a novel SLP-76-as-
sociated protein-tyrosine kinase that phosphorylates SLP-76 in
the modulation of early activation events in T cells.
We showed previously that the SAM domain of SLP-76
mediates adaptor oligomer formation and that its deletion
causes loss ofmicrocluster formation, NFAT transcription, and
IL-2 production (22). To fully understand the function of the
SAM domain, we hypothesized that it might also bind other
kinases. In this context, given the importance of the SAM
domain and the fact that SAM domains can bind to other SAM
domains (35), we hypothesized that the domain might recruit a
SAM domain-carrying kinase. Because no binding partner of
the SLP-76 SAM domain was known, we mined the KinBase
database, which identified two N-terminal SAM domain
kinases, ACK1 and ACK2 (Fig. 1A). Quantitative real-time-
PCR, Western blotting and microarray (Immgen), and RNA
sequencing data3 confirmed ACK1 expression in T cells
(supplemental Fig. S1). Interestingly, however, the related
ACK2 was not expressed in T cells (supplemental Fig. S1) (40).
ACK2, contrary to ACK1, lacks ubiquitin-associated (UBA)
and mitogen-induced gene 6 (Mig-6) homology domains as
well as most of the C terminus (41). However, both ACK1 and
ACK2 are distinct in having an SH3 and Cdc42- and Rac-inter-
active binding motif (CRIB) domain not found in other non-
receptor tyrosine kinases. Therefore, they are likely to differ in
their mechanism of action. Homologous proteins are found in
the mouse, cow, Drosophila melanogaster, and Caenorhabditis
elegans (42, 43). Human and mouse ACK1 proteins are highly
conserved (93.4% identity) (supplemental Fig. S1).
Our findings clearly showed that the loss of the SLP-76 SAM
domain abrogated its ability to bind to ACK1. Interestingly, the
mutation of the proximal 3Y tyrosines (Tyr-113, Tyr-128, and
Tyr-145) also disrupted this interaction. Single mutation of
either the Tyr-128 or Tyr-145 residue disrupted ACK1-SLP76
complex formation. Whether the proximity of the tyrosines to
the SAM domain influences SAM function (i.e. alters the con-
formation) orwhether they exert an effect via an aspect of direct
recognition is not clear. In either case, these findings present
ACK1 as a new binding partner of SLP-76 with clear evidence
that this binding occurred via the N terminus of the SLP-76
SAM domain. The interaction may account in part for the
importance of the SLP-76 SAMdomain inmediating optimal T
cell activation.
In this context, we also found that ACK1 has the capacity to
specifically phosphorylate the SLP-76 Tyr-113, Tyr-128, and
Tyr-145 residues, as shown by its failure to phosphorylate 3Y3F
mutants. Previous studies by us and others identifiedZAP-70 as
the kinase responsible for SLP-76 phosphorylation (27, 28).
Several studies have established a role of ACK1 as a major inte-
grator of receptor signals in pathways like EGF receptor, IGF-1,
and insulin (39). Whether ZAP-70 and ACK1 act indepen-
dently or in synergy remains to be investigated. ACK1-medi-
ated phosphorylation was dependent on its binding to SLP-76
and was abrogated by loss of the SLP-76 SAM domain. Con-
trarily, there is no evidence of ZAP-70 binding to SLP-76, mak-
ing ACK1 a unique kinase (27). Because SAM-deficient ACK1
lacks kinase activity (34, 44), its phosphorylation could be a
direct consequence of SAM-SAM interaction. This is the first
reported occurrence of kinase activity mediated by SAM
domain binding in T cells. The ACK1-SLP76 complex is there-
fore likely to operate in an autoregulatory manner, where SAM
binding is needed to recruit ACK1, which, in turn, phosphory-
lates tyrosines. Loss of tyrosine phosphorylation of 3Y motifs
upon singlemutations (Y128F or Y145F) suggests cooperativity
among tyrosines, as noted previously (45).
Further studies will be needed to assess whether ACK1 can
also cooperate with the interleukin 2 tyrosine kinase pathway,
where the kinase phosphorylates PLC1 for the regulation of
calciummobilization (30). ACK1may also cooperate with rest-
ing lymphocyte kinase, which, as we showed previously, can
also phosphorylate SLP-76 to enhance the activation of PLC1,
ERK, and NFAT/AP-1 transcription (31).
Previous studies have shown that mutation of Tyr-113 and
Tyr-128 of SLP-76 (the residues needed for binding to VAV1
and NCK (non-catalytic region of tyrosine kinase adaptor pro-
tein)) results in defective PLC1 phosphorylation, calcium flux,
andNFAT activity (37). Because ACK1 directly phosphorylates
3Y, we assessed its influence on calcium flux in primary CD4
cells. Under suboptimal anti-CD3 concentrations, exogenous
ACK1 led to enhanced calcium flux. This result implies that
ACK1-mediated tyrosine phosphorylation of SLP-76 influ-
ences signaling via the PLC1-calcium axis, which feeds into
increased nuclear translocation of NFAT. This was confirmed
by an increase in NFAT/AP1 luciferase promoter activity
observed upon anti-CD3 stimulation in ACK1-transfected Jur-
kat T cells.
SLP-76 also has a well documented role in cytoskeleton reor-
ganization and motility (46, 47). Our findings also indicated
involvement of ACK1 in T cell motility. Motility requires alter-
ations in the affinity of LFA-1 to its ligand ICAM-1 by the sig-
naling events that induce the contractile forces needed for cell
movement. Therefore, motility was measured as random
movements on ICAM-1-coated plates. Overexpression of
ACK1 in preactivated primary CD4 T cells decreased the
motility on ICAM-1, which was reversed by inhibiting ACK1
activity using a small molecule inhibitor, AIM-100. The inter-
play of the LFA-1/ACK1 axis with other integrin signaling pro-
teins remains to be determined. Blocked motility by ACK1
could be linked to a reduced LFA-1 cluster or changes in ADAP
(adhesion- and degranulation-promoting adapter protein)
binding to SLP-76, involved in outside-in signaling (47). The
detailed role of ACK1 in motility, polarization, and synapse
formation needs to be address in future studies, but the data
gathered in this study indicate that ACK1 could well play a
critical role in T cell immune responses.
Experimental procedures
Reagents, antibodies, and cell culture
Antibodies used were as follows: hamster anti-mouse CD3
(145-2C11, BioXCell), mouse anti-human CD3 (OKT3, BioX-
Cell), mouse anti-Tyr(P) (4G10, Millipore), rabbit anti-GFP
(Abcam), anti-Myc (Abcam), rabbit anti-ACK1 (Abcam, Santa3 S. L. McArdel and A. H. Sharpe, unpublished data.
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Cruz Biotechnology, and Novus Biologicals), and mouse
anti-HA (Cell Signaling Technology). We also used an ACK1
inhibitor (AIM-100, Calbiochem) and Indo-1 dye (Invitrogen).
Lab-Tek chambered coverglasses were from Nunc. The 3
NFAT/AP1 plasmid, SLP-76-EYFP, SLP76-His, and -SAM
SLP-76 vectors have been described previously (22). 3Y3F-
EYFP and 3Y3F-HAwere subcloned into the pEYFP-N1 (Clon-
tech) and pSR- vectors, respectively. Single mutants (HA-Y128
and HA-Y145) were cloned into pSR-. ACK1 plasmids were a
kind gift from Dr. Scott A. Weed (West Virginia University).
Jurkat and primary T cells were maintained in RPMI 1640
medium (Sigma) supplemented with antibiotics (penicillin/
streptomycin) and 10% FBS at 37 °C and 5% CO2. HEK293T
cells were maintained in DMEM (Sigma) with penicillin/strep-
tomycin antibiotics and 10% FBS.
Mice and T cell enrichment
DO11.10 mice were housed at Central Biological Services
(Cambridge University). T cells were enriched from spleno-
cytes and lymph nodes for CD4 using a negative selection
column kit (R&D Systems) or MACS microbeads magnetic
beads (Miltenyi Biotech). The purity of isolated CD4 T cells
was greater than 90%.
Ratiometric calcium flux and cell motility assay
Preactivated and rested (24 h) primary CD4 cells were
transfectedwithMyc-ACK1 for 24 h andwashedwith cell load-
ing medium (PBS with 1 mM calcium). Cells were loaded with
1.5 M Indo-1 dye (Invitrogen) at 37 °C for 30 min. Excess free
dye was removed by two washes with cell loadingmedium. The
ratio of bound (405 nm) and free (485 nm) calcium was mea-
sured on a CyAn flow cytometer (Dako Cytomation) (48) upon
TCR engagement by hamster anti-CD3 (2C11) plus anti-
hamster cross-linking secondary antibody. The recorded
data were analyzed and plotted using Summit software
(Beckman Coulter).
To perform the motility assay, murine CD4 T cells were
activated with plate-bound anti-CD3 and CD28 (2g and 1g,
respectively) for 48 h.Activated cellswere then transfectedwith
2 g of HA-ACK1 or empty vector control per 1  106 cells
using the Amaxa Nucleofector Kit (Lonza). Following transfec-
tion, cells were maintained in culture without anti-CD3/CD28
for an additional 24 h (i.e. rested). Cells were then tracked on
ICAM-1-Fc (2 g/ml)-coated plates. Alternatively, cells were
treated with 2 M of ACK1 inhibitor (AIM-100) for 30 min
before imaging. Images were acquired every 10 s for 20 min.
Images were processed using Zeiss LSM510 confocal software
and analyzed by Volocity software (Improvision).
Transfections, Western blotting, immunoprecipitation,
luciferase promoter assay, and RT-PCR
Primary T cells were transfected by microporation using the
Amaxa Nucleofector Kit (Lonza) according to the instructions
of the supplier, with modifications. Prior to pulsing, the cells
were incubated on ice for 10 min and for an additional minute
in Amaxa solution A plus B (4.5:1) with plasmid(s) at room
temperature. Jurkat cells were transfected as described previ-
ously (49) for 24 h. 24 h after transfection, the cells were stim-
ulated with soluble anti-CD3 for 5 min. Cell lysates were then
prepared on ice for immunoprecipitation. HEK293T cells were
transfected using PEI by mixing with 2 g of DNA in Opti-
MEM (without FBS and antibiotics), followed by incubation at
room temperature for 7min, afterwhich themixturewas added
to cells dropwise. Cells were harvested after 24 h, and lysates
were prepared for immunoprecipitation and Western blotting
as described previously (49). Tyrosine phosphorylation blots
were probed with anti-Tyr(P) (4G10) antibody. For the NFAT-
AP1 promoter activity assay, the luciferase reporter plasmid
containing 3NFAT/AP1 binding sites was co-transfected
with the control Renilla plasmid pRL-TK (Promega) together
with ACK1 or empty vector into Jurkat cells for 24 h. 24 h after
transfection, the cells were incubatedwith soluble anti-CD3 for
an additional 6 h, and promoter activity was measured using a
Dual-Luciferase assay kit (Promega) on aMicroLumat Lumina-
tor (Berthold). For real-time qPCR, RNAwas isolated using the
RNAeasy kit (Qiagen) and converted to cDNA using the cDNA
reverse transcription kit (Applied Biosystem). Expression was
quantified using commercially available primer sets against
ACK1 andGAPDH (Sigma) on anABApplied 7500 instrument
according to the instructions of the manufacturer. All data are
presented as relative expression levels normalized to GAPDH
expression.
In situ proximity ligation assay
PLA was performed using Duolink in situ PLA reagents (50)
in HEK293T cells transfected with Myc-ACK1 (to be detected
by anti-Myc antibody), and HA-SLP-76 (to be detected by
anti-HA antibody). At 24 h, cells on slides were blocked with
Duolink blocking stock, followed by the application of two PLA
probes in 1 antibody diluent (anti-Myc plus anti-HA). The
slides were washed for 5 min twice in wash buffer (1 TBS-T,
Tris-buffered saline-Tween 20) and processed for hybridiza-
tion using Duolink hybridization stock, followed by incubation
for 15 min at 37 °C. Duolink ligation was performed with ligase
for 15 min at 37 °C. Amplification was then achieved using
Duolink amplification stock containing polymerase for 90 min
at 37 °C. DNA was stained with DAPI. Each dot represents the
close proximity of two interacting proteins within the cells.
Confocal microscopy
HA-ACK1 and SLP76-EYFP were co-transfected into Jurkat
T cells by electroporation (unipolar pulse, 310 V; 10 ms on a
BTX electroporator). Cells were then incubated at 37 °C over-
night. Prior to staining, cells were stimulated by soluble or cov-
erslip-precoated anti-CD3 (2g) and fixed in 4% formaldehyde,
followed by staining with Alexa Flour 647-conjugated anti-
mouse Ig (Molecular Probes) to detect mouse anti-HA anti-
body. Cell images were acquired using a Nikon A1R confocal
microscope with a plan-apochromatic violet-corrected 1.4
numerical aperture 60 magnifying oil immersion objective.
Images were acquired using one-way sequential line scans. YFP
was excited at 488 nm with a laser power of 6.8 arbitrary units
(AU), and its emission was collected at 525/50 nm with a PMT
gain of 120 AU. The HA-ACK1 signal was excited at 637.3 nm
with a laser power of 20.8 AU and collected at 595/50 nm with
a PMT gain of 129 AU. The axial step size was 300 nm, with
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20–40 image planes per z stack. No offset was applied on the
images (51).
Colocalization analysis
To quantify the degree of colocalization between HA-ACK1
and SLP76-EYFP, Pearson’s correlation coefficient was evalu-
ated by using the co-localization threshold plugin in ImageJ
software (52) with autothreshold settings (53). 3D microscopic
images were used for the analysis, where PPC values were
obtained to indicate co-localization.
Statistical analysis
All statistical analyses were performed using Prism 6 soft-
ware (GraphPad Software). One-way analysis of variance and
unpaired Student’s t test were used to test the significance of
changes between groups.
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1Supplementary Fig S1. ACK1 and ACK2 expression in T-cells (A) Left panel, quantitative RT-PCR measurement of
ACK1 expression in CD4+ primary T-cells upon anti-CD3 stimulation in primary T-cells. Middle panel, ACK1 (red) and
ACK2 (silver) expression from Immgen array expression database (CD4 T conventional (Tcon), T Regulatory (Treg) and
transgenic pancreatic-infiltrating T-cells (BDC)). Right panel, RNA-seq data from expression array (http://www.th-
express.org/#browse), showing fold change in RNA level as compared to naïve CD4+ cells (40). (B) Western blot showing
ACK1 protein expression in various cell types. (C) Sequence alignment of human and mouse ACK1 (Tnk2) proteins. (D)
Antibody specificity controls for confocal microscopy experiments shown in figure 3.
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